Table 3.
Transcranial Magnetic Stimulation Measures of the Ipsilesional Side in the 2 Treatment Groupsa
| Experimental | Control | |
|---|---|---|
| rMT 1 | 64.54 ± 5.62 | 60.78 ± 7.72 |
| rMT 2 | 62.54 ± 4.45 | 59.33 ± 7.07 |
| rMT 3 | 62.00 ± 4.82 | 66.20 ± 7.72 |
| aMT 1 | 58.08 ± 5.94 | 52.78 ± 6.92 |
| aMT 2 | 52.73 ± 5.01 | 48.11 ± 5.42 |
| aMT 3 | 52.27 ± 4.40 | 51.50 ± 5.78 |
| COGx 1 | 4.36 ± 0.36 | 4.07 ± 0.32 |
| COGx 2 | 5.53 ± 0.32 | 4.06 ± 0.30 |
| COGx 3 | 4.53 ± 0.31 | 3.95 ± 0.65 |
| COGy 1 | 2.63 ± 0.54 | 3.82 ± 0.44 |
| COGy 2 | 2.82 ± 0.41 | 3.87 ± 0.56 |
| COGy 3 | 2.18 ± 0.43 | 3.74 ± 0.27 |
a
Resting motor threshold (rMT), active motor threshold (aMT), and centers of gravity for the x-coordinate (COGx) and y-coordinate (COGy) collected in the extensor digitorum communis muscle of the more-affected forearm at baseline (1), after 2 weeks (2), and at 4-month follow-up (3). Data are expressed as mean ± standard error.